|
C1ORF83 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.444020E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.774200E-02 |
| Normal-vs-Stage2 |
3.578000E-01 |
| Normal-vs-Stage3 |
1.876560E-01 |
| Normal-vs-Stage4 |
7.204000E-01 |
| Stage1-vs-Stage2 |
6.011400E-01 |
| Stage1-vs-Stage3 |
6.847200E-01 |
| Stage1-vs-Stage4 |
6.159800E-01 |
| Stage2-vs-Stage3 |
8.584600E-01 |
| Stage2-vs-Stage4 |
9.180400E-01 |
| Stage3-vs-Stage4 |
8.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.194630E-01 |
| Normal-vs-AfricanAmerican |
2.433600E-01 |
| Normal-vs-Asian |
1.343200E-01 |
| Caucasian-vs-AfricanAmerican |
9.737600E-01 |
| Caucasian-vs-Asian |
5.683800E-01 |
| AfricanAmerican-vs-Asian |
5.832000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.757600E-02 |
| Normal-vs-Female |
5.225600E-01 |
| Male-vs-Female |
2.641700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.165000E-01 |
| Normal-vs-Extreme_Weight |
8.382900E-03 |
| Normal-vs-Obese |
1.245040E-01 |
| Normal-vs-Extreme_Obese |
6.822200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.800790E-01 |
| Normal_Weight-vs-Obese |
8.108200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.661200E-01 |
| Extreme_Weight-vs-Obese |
1.486620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.453000E-01 |
| Obese-vs-Extreme_Obese |
8.892600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.604400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.439400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.008500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.624500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.828600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.581400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.726070E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.218000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.234100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.347200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.063840E-01 |
| Normal-VS-Type2 PRCC |
4.920200E-02 |
| Normal-VS-KIRP CIMP |
6.952800E-01 |
| Normal-VS-Unclassified PRCC |
6.279600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.879000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.552200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.454500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.765000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.224100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.926000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.345800E-02 |
| Normal-vs-N1 |
8.132000E-01 |
| Normal-vs-N2 |
9.929000E-01 |
| N0-vs-N1 |
2.201400E-01 |
| N0-vs-N2 |
3.694400E-01 |
| N1-vs-N2 |
9.145000E-01 |
|
|
